Global GMP-grade AAV Vector Manufacturing Service Supply, Demand and Key Producers, 2026-2032
The global GMP-grade AAV Vector Manufacturing Service market size is expected to reach $ 2085 million by 2032, rising at a market growth of 12.9% CAGR during the forecast period (2026-2032).
GMP-grade AAV vector manufacturing services refer to contract development and manufacturing activities performed under pharmaceutical good manufacturing practice requirements for recombinant adeno-associated viral vectors. The service scope generally includes process development, cell-bank establishment, GMP drug-substance manufacturing, purification, formulation, sterile filtration, fill and finish, quality testing, stability studies, batch release and regulatory support. Common production routes include adherent or suspension HEK293 transient transfection, stable producer-cell platforms and baculovirus-Sf9 systems. Key upstream inputs include GMP-grade transfer plasmids, Rep/Cap plasmids, helper plasmids, production cells, culture media, transfection reagents, nucleases, chromatography resins, filtration consumables, single-use bioreactors and analytical reagents. Major downstream customers include gene therapy developers, biotechnology companies, pharmaceutical companies, hospital translational platforms and research institutions, with applications covering IND submissions, clinical trials, process validation and commercial supply. The industry's overall gross margin is generally estimated at approximately 25%-40%.
The global market currently consists of large integrated CDMOs, specialized AAV manufacturers and regional cell and gene therapy service providers. Large CDMOs compete through global quality systems, multi-site manufacturing networks, commercial-batch experience and integrated fill-and-finish capabilities. Specialized AAV providers differentiate themselves through high-yield HEK293 cells, proprietary plasmid systems, capsid technologies and dedicated AAV facilities. Chinese and other Asia-Pacific providers compete primarily through cost, delivery speed, early-clinical project experience and integrated service offerings. Because clinical programs require consistent technology transfer, comparability, stability data and regulatory documentation, changing suppliers after a program enters GMP manufacturing is substantially more difficult than switching research-grade packaging vendors.
Demand growth is supported by the progression of AAV gene therapy programs into clinical development, indication expansion for approved products, tissue-specific capsid development and increasing outsourcing by small and mid-sized biotechnology companies. Neurological, ophthalmic, neuromuscular and rare metabolic diseases remain important sources of GMP projects, while dual-AAV systems, engineered capsids and gene-editing delivery create additional process-development requirements. Growth is becoming less dependent on the total number of discovery programs and more dependent on whether candidates reach IND submission, advance into later-stage trials and generate repeat manufacturing orders. Tightening expectations for product quality, manufacturing consistency, potency assays and comparability favor providers with integrated analytical, quality and regulatory capabilities.
Manufacturing technology is gradually shifting from adherent culture and highly customized workflows toward suspension culture, platform processes and stable producer-cell systems. Suspension HEK293 transient transfection remains the principal route for clinical-scale expansion, but plasmid and transfection-reagent costs, batch variability and scale-up complexity remain significant. Stable producer cells, dual-plasmid systems, baculovirus-Sf9 platforms and plasmid-free technologies may lower raw-material costs and improve consistency. Downstream competition is moving beyond vector-genome titer toward enrichment of full capsids, removal of empty and partially packaged particles and tighter control of host-cell DNA, host-cell proteins, residual plasmids and replication-competent AAV.
The main constraints include gene therapy financing and pipeline reprioritization, underutilized GMP capacity, high program attrition, elevated production costs and clinical safety events that may delay development. Some facilities built during the earlier investment cycle have experienced slower order ramp-up than initially expected, encouraging CDMOs to compete through platform processes, shorter timelines, flexible batch sizes and more aggressive commercial terms. AAV also faces inherent limitations involving payload capacity, pre-existing neutralizing antibodies, repeat dosing, high-dose toxicity and tissue-targeting efficiency. Lipid nanoparticles, nonviral delivery and other in vivo gene-editing platforms may therefore substitute for AAV in selected indications. Long-term leadership will depend more on productivity, product quality, successful regulatory filings, commercial supply capability and facility utilization than on nominal installed capacity alone.
This report studies the global GMP-grade AAV Vector Manufacturing Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for GMP-grade AAV Vector Manufacturing Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of GMP-grade AAV Vector Manufacturing Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global GMP-grade AAV Vector Manufacturing Service total market, 2021-2032, (USD Million)
Global GMP-grade AAV Vector Manufacturing Service total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: GMP-grade AAV Vector Manufacturing Service total market, key domestic companies, and share, (USD Million)
Global GMP-grade AAV Vector Manufacturing Service revenue by player, revenue and market share 2021-2026, (USD Million)
Global GMP-grade AAV Vector Manufacturing Service total market by Type, CAGR, 2021-2032, (USD Million)
Global GMP-grade AAV Vector Manufacturing Service total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global GMP-grade AAV Vector Manufacturing Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Lonza, Charles River Laboratories, Catalent, AGC Biologics, SK pharmteco, OXB, Forge Biologics, Viralgen, Andelyn Biosciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world GMP-grade AAV Vector Manufacturing Service market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global GMP-grade AAV Vector Manufacturing Service Market, By Region:
1. How big is the global GMP-grade AAV Vector Manufacturing Service market?
2. What is the demand of the global GMP-grade AAV Vector Manufacturing Service market?
3. What is the year over year growth of the global GMP-grade AAV Vector Manufacturing Service market?
4. What is the total value of the global GMP-grade AAV Vector Manufacturing Service market?
5. Who are the Major Players in the global GMP-grade AAV Vector Manufacturing Service market?
6. What are the growth factors driving the market demand?
GMP-grade AAV vector manufacturing services refer to contract development and manufacturing activities performed under pharmaceutical good manufacturing practice requirements for recombinant adeno-associated viral vectors. The service scope generally includes process development, cell-bank establishment, GMP drug-substance manufacturing, purification, formulation, sterile filtration, fill and finish, quality testing, stability studies, batch release and regulatory support. Common production routes include adherent or suspension HEK293 transient transfection, stable producer-cell platforms and baculovirus-Sf9 systems. Key upstream inputs include GMP-grade transfer plasmids, Rep/Cap plasmids, helper plasmids, production cells, culture media, transfection reagents, nucleases, chromatography resins, filtration consumables, single-use bioreactors and analytical reagents. Major downstream customers include gene therapy developers, biotechnology companies, pharmaceutical companies, hospital translational platforms and research institutions, with applications covering IND submissions, clinical trials, process validation and commercial supply. The industry's overall gross margin is generally estimated at approximately 25%-40%.
The global market currently consists of large integrated CDMOs, specialized AAV manufacturers and regional cell and gene therapy service providers. Large CDMOs compete through global quality systems, multi-site manufacturing networks, commercial-batch experience and integrated fill-and-finish capabilities. Specialized AAV providers differentiate themselves through high-yield HEK293 cells, proprietary plasmid systems, capsid technologies and dedicated AAV facilities. Chinese and other Asia-Pacific providers compete primarily through cost, delivery speed, early-clinical project experience and integrated service offerings. Because clinical programs require consistent technology transfer, comparability, stability data and regulatory documentation, changing suppliers after a program enters GMP manufacturing is substantially more difficult than switching research-grade packaging vendors.
Demand growth is supported by the progression of AAV gene therapy programs into clinical development, indication expansion for approved products, tissue-specific capsid development and increasing outsourcing by small and mid-sized biotechnology companies. Neurological, ophthalmic, neuromuscular and rare metabolic diseases remain important sources of GMP projects, while dual-AAV systems, engineered capsids and gene-editing delivery create additional process-development requirements. Growth is becoming less dependent on the total number of discovery programs and more dependent on whether candidates reach IND submission, advance into later-stage trials and generate repeat manufacturing orders. Tightening expectations for product quality, manufacturing consistency, potency assays and comparability favor providers with integrated analytical, quality and regulatory capabilities.
Manufacturing technology is gradually shifting from adherent culture and highly customized workflows toward suspension culture, platform processes and stable producer-cell systems. Suspension HEK293 transient transfection remains the principal route for clinical-scale expansion, but plasmid and transfection-reagent costs, batch variability and scale-up complexity remain significant. Stable producer cells, dual-plasmid systems, baculovirus-Sf9 platforms and plasmid-free technologies may lower raw-material costs and improve consistency. Downstream competition is moving beyond vector-genome titer toward enrichment of full capsids, removal of empty and partially packaged particles and tighter control of host-cell DNA, host-cell proteins, residual plasmids and replication-competent AAV.
The main constraints include gene therapy financing and pipeline reprioritization, underutilized GMP capacity, high program attrition, elevated production costs and clinical safety events that may delay development. Some facilities built during the earlier investment cycle have experienced slower order ramp-up than initially expected, encouraging CDMOs to compete through platform processes, shorter timelines, flexible batch sizes and more aggressive commercial terms. AAV also faces inherent limitations involving payload capacity, pre-existing neutralizing antibodies, repeat dosing, high-dose toxicity and tissue-targeting efficiency. Lipid nanoparticles, nonviral delivery and other in vivo gene-editing platforms may therefore substitute for AAV in selected indications. Long-term leadership will depend more on productivity, product quality, successful regulatory filings, commercial supply capability and facility utilization than on nominal installed capacity alone.
This report studies the global GMP-grade AAV Vector Manufacturing Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for GMP-grade AAV Vector Manufacturing Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of GMP-grade AAV Vector Manufacturing Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global GMP-grade AAV Vector Manufacturing Service total market, 2021-2032, (USD Million)
Global GMP-grade AAV Vector Manufacturing Service total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: GMP-grade AAV Vector Manufacturing Service total market, key domestic companies, and share, (USD Million)
Global GMP-grade AAV Vector Manufacturing Service revenue by player, revenue and market share 2021-2026, (USD Million)
Global GMP-grade AAV Vector Manufacturing Service total market by Type, CAGR, 2021-2032, (USD Million)
Global GMP-grade AAV Vector Manufacturing Service total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global GMP-grade AAV Vector Manufacturing Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Lonza, Charles River Laboratories, Catalent, AGC Biologics, SK pharmteco, OXB, Forge Biologics, Viralgen, Andelyn Biosciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world GMP-grade AAV Vector Manufacturing Service market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global GMP-grade AAV Vector Manufacturing Service Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- GMP Drug Substance Manufacturing
- GMP Drug Substance and Fill-Finish
- End-to-End CMC and Manufacturing
- Early Clinical Manufacturing
- Late-stage Clinical Manufacturing
- PPQ and Commercial Manufacturing
- Adherent HEK293
- Suspension HEK293
- Baculovirus-Sf9
- Other
- Biotechnology Companies
- Pharmaceutical Companies
- Other
- Thermo Fisher Scientific
- Lonza
- Charles River Laboratories
- Catalent
- AGC Biologics
- SK pharmteco
- OXB
- Forge Biologics
- Viralgen
- Andelyn Biosciences
- Resilience
- Advanced Therapies
- IDT Biologika
- Matica Bio
- Takara Bio
- VectorBuilder
- GenScript ProBio
- PackGene Biotech
1. How big is the global GMP-grade AAV Vector Manufacturing Service market?
2. What is the demand of the global GMP-grade AAV Vector Manufacturing Service market?
3. What is the year over year growth of the global GMP-grade AAV Vector Manufacturing Service market?
4. What is the total value of the global GMP-grade AAV Vector Manufacturing Service market?
5. Who are the Major Players in the global GMP-grade AAV Vector Manufacturing Service market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 GMP-grade AAV Vector Manufacturing Service Introduction
1.2 World GMP-grade AAV Vector Manufacturing Service Market Size & Forecast (2021 & 2025 & 2032)
1.3 World GMP-grade AAV Vector Manufacturing Service Total Market by Region (by Headquarter Location)
1.3.1 World GMP-grade AAV Vector Manufacturing Service Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032)
1.3.3 China Based Company GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032)
1.3.4 Europe Based Company GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032)
1.3.5 Japan Based Company GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032)
1.3.6 South Korea Based Company GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032)
1.3.7 ASEAN Based Company GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032)
1.3.8 India Based Company GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 GMP-grade AAV Vector Manufacturing Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032)
2.2 World GMP-grade AAV Vector Manufacturing Service Consumption Value by Region
2.2.1 World GMP-grade AAV Vector Manufacturing Service Consumption Value by Region (2021-2026)
2.2.2 World GMP-grade AAV Vector Manufacturing Service Consumption Value Forecast by Region (2027-2032)
2.3 United States GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032)
2.4 China GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032)
2.5 Europe GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032)
2.6 Japan GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032)
2.7 South Korea GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032)
2.8 ASEAN GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032)
2.9 India GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032)
3 WORLD GMP-GRADE AAV VECTOR MANUFACTURING SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World GMP-grade AAV Vector Manufacturing Service Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global GMP-grade AAV Vector Manufacturing Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for GMP-grade AAV Vector Manufacturing Service in 2025
3.2.3 Global Concentration Ratios (CR8) for GMP-grade AAV Vector Manufacturing Service in 2025
3.3 GMP-grade AAV Vector Manufacturing Service Company Evaluation Quadrant
3.4 GMP-grade AAV Vector Manufacturing Service Market: Overall Company Footprint Analysis
3.4.1 GMP-grade AAV Vector Manufacturing Service Market: Region Footprint
3.4.2 GMP-grade AAV Vector Manufacturing Service Market: Company Product Type Footprint
3.4.3 GMP-grade AAV Vector Manufacturing Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: GMP-grade AAV Vector Manufacturing Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: GMP-grade AAV Vector Manufacturing Service Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: GMP-grade AAV Vector Manufacturing Service Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: GMP-grade AAV Vector Manufacturing Service Consumption Value Comparison
4.2.1 United States VS China: GMP-grade AAV Vector Manufacturing Service Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: GMP-grade AAV Vector Manufacturing Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based GMP-grade AAV Vector Manufacturing Service Companies and Market Share, 2021-2026
4.3.1 United States Based GMP-grade AAV Vector Manufacturing Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies GMP-grade AAV Vector Manufacturing Service Revenue, (2021-2026)
4.4 China Based Companies GMP-grade AAV Vector Manufacturing Service Revenue and Market Share, 2021-2026
4.4.1 China Based GMP-grade AAV Vector Manufacturing Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies GMP-grade AAV Vector Manufacturing Service Revenue, (2021-2026)
4.5 Rest of World Based GMP-grade AAV Vector Manufacturing Service Companies and Market Share, 2021-2026
4.5.1 Rest of World Based GMP-grade AAV Vector Manufacturing Service Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies GMP-grade AAV Vector Manufacturing Service Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World GMP-grade AAV Vector Manufacturing Service Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 GMP Drug Substance Manufacturing
5.2.2 GMP Drug Substance and Fill-Finish
5.2.3 End-to-End CMC and Manufacturing
5.3 Market Segment by Type
5.3.1 World GMP-grade AAV Vector Manufacturing Service Market Size by Type (2021-2026)
5.3.2 World GMP-grade AAV Vector Manufacturing Service Market Size by Type (2027-2032)
5.3.3 World GMP-grade AAV Vector Manufacturing Service Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DEVELOPMENT STAGE
6.1 World GMP-grade AAV Vector Manufacturing Service Market Size Overview by Development Stage: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Development Stage
6.2.1 Early Clinical Manufacturing
6.2.2 Late-stage Clinical Manufacturing
6.2.3 PPQ and Commercial Manufacturing
6.3 Market Segment by Development Stage
6.3.1 World GMP-grade AAV Vector Manufacturing Service Market Size by Development Stage (2021-2026)
6.3.2 World GMP-grade AAV Vector Manufacturing Service Market Size by Development Stage (2027-2032)
6.3.3 World GMP-grade AAV Vector Manufacturing Service Market Size Market Share by Development Stage (2027-2032)
7 MARKET ANALYSIS BY PRODUCTION PLATFORM
7.1 World GMP-grade AAV Vector Manufacturing Service Market Size Overview by Production Platform: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Production Platform
7.2.1 Adherent HEK293
7.2.2 Suspension HEK293
7.2.3 Baculovirus-Sf9
7.2.4 Other
7.3 Market Segment by Production Platform
7.3.1 World GMP-grade AAV Vector Manufacturing Service Market Size by Production Platform (2021-2026)
7.3.2 World GMP-grade AAV Vector Manufacturing Service Market Size by Production Platform (2027-2032)
7.3.3 World GMP-grade AAV Vector Manufacturing Service Market Size Market Share by Production Platform (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World GMP-grade AAV Vector Manufacturing Service Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Biotechnology Companies
8.2.2 Pharmaceutical Companies
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World GMP-grade AAV Vector Manufacturing Service Market Size by Application (2021-2026)
8.3.2 World GMP-grade AAV Vector Manufacturing Service Market Size by Application (2027-2032)
8.3.3 World GMP-grade AAV Vector Manufacturing Service Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific Details
9.1.2 Thermo Fisher Scientific Major Business
9.1.3 Thermo Fisher Scientific GMP-grade AAV Vector Manufacturing Service Product and Services
9.1.4 Thermo Fisher Scientific GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Thermo Fisher Scientific Recent Developments/Updates
9.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.2 Lonza
9.2.1 Lonza Details
9.2.2 Lonza Major Business
9.2.3 Lonza GMP-grade AAV Vector Manufacturing Service Product and Services
9.2.4 Lonza GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Lonza Recent Developments/Updates
9.2.6 Lonza Competitive Strengths & Weaknesses
9.3 Charles River Laboratories
9.3.1 Charles River Laboratories Details
9.3.2 Charles River Laboratories Major Business
9.3.3 Charles River Laboratories GMP-grade AAV Vector Manufacturing Service Product and Services
9.3.4 Charles River Laboratories GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Charles River Laboratories Recent Developments/Updates
9.3.6 Charles River Laboratories Competitive Strengths & Weaknesses
9.4 Catalent
9.4.1 Catalent Details
9.4.2 Catalent Major Business
9.4.3 Catalent GMP-grade AAV Vector Manufacturing Service Product and Services
9.4.4 Catalent GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Catalent Recent Developments/Updates
9.4.6 Catalent Competitive Strengths & Weaknesses
9.5 AGC Biologics
9.5.1 AGC Biologics Details
9.5.2 AGC Biologics Major Business
9.5.3 AGC Biologics GMP-grade AAV Vector Manufacturing Service Product and Services
9.5.4 AGC Biologics GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 AGC Biologics Recent Developments/Updates
9.5.6 AGC Biologics Competitive Strengths & Weaknesses
9.6 SK pharmteco
9.6.1 SK pharmteco Details
9.6.2 SK pharmteco Major Business
9.6.3 SK pharmteco GMP-grade AAV Vector Manufacturing Service Product and Services
9.6.4 SK pharmteco GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 SK pharmteco Recent Developments/Updates
9.6.6 SK pharmteco Competitive Strengths & Weaknesses
9.7 OXB
9.7.1 OXB Details
9.7.2 OXB Major Business
9.7.3 OXB GMP-grade AAV Vector Manufacturing Service Product and Services
9.7.4 OXB GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 OXB Recent Developments/Updates
9.7.6 OXB Competitive Strengths & Weaknesses
9.8 Forge Biologics
9.8.1 Forge Biologics Details
9.8.2 Forge Biologics Major Business
9.8.3 Forge Biologics GMP-grade AAV Vector Manufacturing Service Product and Services
9.8.4 Forge Biologics GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Forge Biologics Recent Developments/Updates
9.8.6 Forge Biologics Competitive Strengths & Weaknesses
9.9 Viralgen
9.9.1 Viralgen Details
9.9.2 Viralgen Major Business
9.9.3 Viralgen GMP-grade AAV Vector Manufacturing Service Product and Services
9.9.4 Viralgen GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Viralgen Recent Developments/Updates
9.9.6 Viralgen Competitive Strengths & Weaknesses
9.10 Andelyn Biosciences
9.10.1 Andelyn Biosciences Details
9.10.2 Andelyn Biosciences Major Business
9.10.3 Andelyn Biosciences GMP-grade AAV Vector Manufacturing Service Product and Services
9.10.4 Andelyn Biosciences GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Andelyn Biosciences Recent Developments/Updates
9.10.6 Andelyn Biosciences Competitive Strengths & Weaknesses
9.11 Resilience
9.11.1 Resilience Details
9.11.2 Resilience Major Business
9.11.3 Resilience GMP-grade AAV Vector Manufacturing Service Product and Services
9.11.4 Resilience GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Resilience Recent Developments/Updates
9.11.6 Resilience Competitive Strengths & Weaknesses
9.12 Advanced Therapies
9.12.1 Advanced Therapies Details
9.12.2 Advanced Therapies Major Business
9.12.3 Advanced Therapies GMP-grade AAV Vector Manufacturing Service Product and Services
9.12.4 Advanced Therapies GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Advanced Therapies Recent Developments/Updates
9.12.6 Advanced Therapies Competitive Strengths & Weaknesses
9.13 IDT Biologika
9.13.1 IDT Biologika Details
9.13.2 IDT Biologika Major Business
9.13.3 IDT Biologika GMP-grade AAV Vector Manufacturing Service Product and Services
9.13.4 IDT Biologika GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 IDT Biologika Recent Developments/Updates
9.13.6 IDT Biologika Competitive Strengths & Weaknesses
9.14 Matica Bio
9.14.1 Matica Bio Details
9.14.2 Matica Bio Major Business
9.14.3 Matica Bio GMP-grade AAV Vector Manufacturing Service Product and Services
9.14.4 Matica Bio GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Matica Bio Recent Developments/Updates
9.14.6 Matica Bio Competitive Strengths & Weaknesses
9.15 Takara Bio
9.15.1 Takara Bio Details
9.15.2 Takara Bio Major Business
9.15.3 Takara Bio GMP-grade AAV Vector Manufacturing Service Product and Services
9.15.4 Takara Bio GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Takara Bio Recent Developments/Updates
9.15.6 Takara Bio Competitive Strengths & Weaknesses
9.16 VectorBuilder
9.16.1 VectorBuilder Details
9.16.2 VectorBuilder Major Business
9.16.3 VectorBuilder GMP-grade AAV Vector Manufacturing Service Product and Services
9.16.4 VectorBuilder GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 VectorBuilder Recent Developments/Updates
9.16.6 VectorBuilder Competitive Strengths & Weaknesses
9.17 GenScript ProBio
9.17.1 GenScript ProBio Details
9.17.2 GenScript ProBio Major Business
9.17.3 GenScript ProBio GMP-grade AAV Vector Manufacturing Service Product and Services
9.17.4 GenScript ProBio GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 GenScript ProBio Recent Developments/Updates
9.17.6 GenScript ProBio Competitive Strengths & Weaknesses
9.18 PackGene Biotech
9.18.1 PackGene Biotech Details
9.18.2 PackGene Biotech Major Business
9.18.3 PackGene Biotech GMP-grade AAV Vector Manufacturing Service Product and Services
9.18.4 PackGene Biotech GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 PackGene Biotech Recent Developments/Updates
9.18.6 PackGene Biotech Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 GMP-grade AAV Vector Manufacturing Service Industry Chain
10.2 GMP-grade AAV Vector Manufacturing Service Upstream Analysis
10.3 GMP-grade AAV Vector Manufacturing Service Midstream Analysis
10.4 GMP-grade AAV Vector Manufacturing Service Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 GMP-grade AAV Vector Manufacturing Service Introduction
1.2 World GMP-grade AAV Vector Manufacturing Service Market Size & Forecast (2021 & 2025 & 2032)
1.3 World GMP-grade AAV Vector Manufacturing Service Total Market by Region (by Headquarter Location)
1.3.1 World GMP-grade AAV Vector Manufacturing Service Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032)
1.3.3 China Based Company GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032)
1.3.4 Europe Based Company GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032)
1.3.5 Japan Based Company GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032)
1.3.6 South Korea Based Company GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032)
1.3.7 ASEAN Based Company GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032)
1.3.8 India Based Company GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 GMP-grade AAV Vector Manufacturing Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032)
2.2 World GMP-grade AAV Vector Manufacturing Service Consumption Value by Region
2.2.1 World GMP-grade AAV Vector Manufacturing Service Consumption Value by Region (2021-2026)
2.2.2 World GMP-grade AAV Vector Manufacturing Service Consumption Value Forecast by Region (2027-2032)
2.3 United States GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032)
2.4 China GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032)
2.5 Europe GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032)
2.6 Japan GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032)
2.7 South Korea GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032)
2.8 ASEAN GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032)
2.9 India GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032)
3 WORLD GMP-GRADE AAV VECTOR MANUFACTURING SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World GMP-grade AAV Vector Manufacturing Service Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global GMP-grade AAV Vector Manufacturing Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for GMP-grade AAV Vector Manufacturing Service in 2025
3.2.3 Global Concentration Ratios (CR8) for GMP-grade AAV Vector Manufacturing Service in 2025
3.3 GMP-grade AAV Vector Manufacturing Service Company Evaluation Quadrant
3.4 GMP-grade AAV Vector Manufacturing Service Market: Overall Company Footprint Analysis
3.4.1 GMP-grade AAV Vector Manufacturing Service Market: Region Footprint
3.4.2 GMP-grade AAV Vector Manufacturing Service Market: Company Product Type Footprint
3.4.3 GMP-grade AAV Vector Manufacturing Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: GMP-grade AAV Vector Manufacturing Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: GMP-grade AAV Vector Manufacturing Service Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: GMP-grade AAV Vector Manufacturing Service Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: GMP-grade AAV Vector Manufacturing Service Consumption Value Comparison
4.2.1 United States VS China: GMP-grade AAV Vector Manufacturing Service Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: GMP-grade AAV Vector Manufacturing Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based GMP-grade AAV Vector Manufacturing Service Companies and Market Share, 2021-2026
4.3.1 United States Based GMP-grade AAV Vector Manufacturing Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies GMP-grade AAV Vector Manufacturing Service Revenue, (2021-2026)
4.4 China Based Companies GMP-grade AAV Vector Manufacturing Service Revenue and Market Share, 2021-2026
4.4.1 China Based GMP-grade AAV Vector Manufacturing Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies GMP-grade AAV Vector Manufacturing Service Revenue, (2021-2026)
4.5 Rest of World Based GMP-grade AAV Vector Manufacturing Service Companies and Market Share, 2021-2026
4.5.1 Rest of World Based GMP-grade AAV Vector Manufacturing Service Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies GMP-grade AAV Vector Manufacturing Service Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World GMP-grade AAV Vector Manufacturing Service Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 GMP Drug Substance Manufacturing
5.2.2 GMP Drug Substance and Fill-Finish
5.2.3 End-to-End CMC and Manufacturing
5.3 Market Segment by Type
5.3.1 World GMP-grade AAV Vector Manufacturing Service Market Size by Type (2021-2026)
5.3.2 World GMP-grade AAV Vector Manufacturing Service Market Size by Type (2027-2032)
5.3.3 World GMP-grade AAV Vector Manufacturing Service Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DEVELOPMENT STAGE
6.1 World GMP-grade AAV Vector Manufacturing Service Market Size Overview by Development Stage: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Development Stage
6.2.1 Early Clinical Manufacturing
6.2.2 Late-stage Clinical Manufacturing
6.2.3 PPQ and Commercial Manufacturing
6.3 Market Segment by Development Stage
6.3.1 World GMP-grade AAV Vector Manufacturing Service Market Size by Development Stage (2021-2026)
6.3.2 World GMP-grade AAV Vector Manufacturing Service Market Size by Development Stage (2027-2032)
6.3.3 World GMP-grade AAV Vector Manufacturing Service Market Size Market Share by Development Stage (2027-2032)
7 MARKET ANALYSIS BY PRODUCTION PLATFORM
7.1 World GMP-grade AAV Vector Manufacturing Service Market Size Overview by Production Platform: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Production Platform
7.2.1 Adherent HEK293
7.2.2 Suspension HEK293
7.2.3 Baculovirus-Sf9
7.2.4 Other
7.3 Market Segment by Production Platform
7.3.1 World GMP-grade AAV Vector Manufacturing Service Market Size by Production Platform (2021-2026)
7.3.2 World GMP-grade AAV Vector Manufacturing Service Market Size by Production Platform (2027-2032)
7.3.3 World GMP-grade AAV Vector Manufacturing Service Market Size Market Share by Production Platform (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World GMP-grade AAV Vector Manufacturing Service Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Biotechnology Companies
8.2.2 Pharmaceutical Companies
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World GMP-grade AAV Vector Manufacturing Service Market Size by Application (2021-2026)
8.3.2 World GMP-grade AAV Vector Manufacturing Service Market Size by Application (2027-2032)
8.3.3 World GMP-grade AAV Vector Manufacturing Service Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific Details
9.1.2 Thermo Fisher Scientific Major Business
9.1.3 Thermo Fisher Scientific GMP-grade AAV Vector Manufacturing Service Product and Services
9.1.4 Thermo Fisher Scientific GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Thermo Fisher Scientific Recent Developments/Updates
9.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.2 Lonza
9.2.1 Lonza Details
9.2.2 Lonza Major Business
9.2.3 Lonza GMP-grade AAV Vector Manufacturing Service Product and Services
9.2.4 Lonza GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Lonza Recent Developments/Updates
9.2.6 Lonza Competitive Strengths & Weaknesses
9.3 Charles River Laboratories
9.3.1 Charles River Laboratories Details
9.3.2 Charles River Laboratories Major Business
9.3.3 Charles River Laboratories GMP-grade AAV Vector Manufacturing Service Product and Services
9.3.4 Charles River Laboratories GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Charles River Laboratories Recent Developments/Updates
9.3.6 Charles River Laboratories Competitive Strengths & Weaknesses
9.4 Catalent
9.4.1 Catalent Details
9.4.2 Catalent Major Business
9.4.3 Catalent GMP-grade AAV Vector Manufacturing Service Product and Services
9.4.4 Catalent GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Catalent Recent Developments/Updates
9.4.6 Catalent Competitive Strengths & Weaknesses
9.5 AGC Biologics
9.5.1 AGC Biologics Details
9.5.2 AGC Biologics Major Business
9.5.3 AGC Biologics GMP-grade AAV Vector Manufacturing Service Product and Services
9.5.4 AGC Biologics GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 AGC Biologics Recent Developments/Updates
9.5.6 AGC Biologics Competitive Strengths & Weaknesses
9.6 SK pharmteco
9.6.1 SK pharmteco Details
9.6.2 SK pharmteco Major Business
9.6.3 SK pharmteco GMP-grade AAV Vector Manufacturing Service Product and Services
9.6.4 SK pharmteco GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 SK pharmteco Recent Developments/Updates
9.6.6 SK pharmteco Competitive Strengths & Weaknesses
9.7 OXB
9.7.1 OXB Details
9.7.2 OXB Major Business
9.7.3 OXB GMP-grade AAV Vector Manufacturing Service Product and Services
9.7.4 OXB GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 OXB Recent Developments/Updates
9.7.6 OXB Competitive Strengths & Weaknesses
9.8 Forge Biologics
9.8.1 Forge Biologics Details
9.8.2 Forge Biologics Major Business
9.8.3 Forge Biologics GMP-grade AAV Vector Manufacturing Service Product and Services
9.8.4 Forge Biologics GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Forge Biologics Recent Developments/Updates
9.8.6 Forge Biologics Competitive Strengths & Weaknesses
9.9 Viralgen
9.9.1 Viralgen Details
9.9.2 Viralgen Major Business
9.9.3 Viralgen GMP-grade AAV Vector Manufacturing Service Product and Services
9.9.4 Viralgen GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Viralgen Recent Developments/Updates
9.9.6 Viralgen Competitive Strengths & Weaknesses
9.10 Andelyn Biosciences
9.10.1 Andelyn Biosciences Details
9.10.2 Andelyn Biosciences Major Business
9.10.3 Andelyn Biosciences GMP-grade AAV Vector Manufacturing Service Product and Services
9.10.4 Andelyn Biosciences GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Andelyn Biosciences Recent Developments/Updates
9.10.6 Andelyn Biosciences Competitive Strengths & Weaknesses
9.11 Resilience
9.11.1 Resilience Details
9.11.2 Resilience Major Business
9.11.3 Resilience GMP-grade AAV Vector Manufacturing Service Product and Services
9.11.4 Resilience GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Resilience Recent Developments/Updates
9.11.6 Resilience Competitive Strengths & Weaknesses
9.12 Advanced Therapies
9.12.1 Advanced Therapies Details
9.12.2 Advanced Therapies Major Business
9.12.3 Advanced Therapies GMP-grade AAV Vector Manufacturing Service Product and Services
9.12.4 Advanced Therapies GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Advanced Therapies Recent Developments/Updates
9.12.6 Advanced Therapies Competitive Strengths & Weaknesses
9.13 IDT Biologika
9.13.1 IDT Biologika Details
9.13.2 IDT Biologika Major Business
9.13.3 IDT Biologika GMP-grade AAV Vector Manufacturing Service Product and Services
9.13.4 IDT Biologika GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 IDT Biologika Recent Developments/Updates
9.13.6 IDT Biologika Competitive Strengths & Weaknesses
9.14 Matica Bio
9.14.1 Matica Bio Details
9.14.2 Matica Bio Major Business
9.14.3 Matica Bio GMP-grade AAV Vector Manufacturing Service Product and Services
9.14.4 Matica Bio GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Matica Bio Recent Developments/Updates
9.14.6 Matica Bio Competitive Strengths & Weaknesses
9.15 Takara Bio
9.15.1 Takara Bio Details
9.15.2 Takara Bio Major Business
9.15.3 Takara Bio GMP-grade AAV Vector Manufacturing Service Product and Services
9.15.4 Takara Bio GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Takara Bio Recent Developments/Updates
9.15.6 Takara Bio Competitive Strengths & Weaknesses
9.16 VectorBuilder
9.16.1 VectorBuilder Details
9.16.2 VectorBuilder Major Business
9.16.3 VectorBuilder GMP-grade AAV Vector Manufacturing Service Product and Services
9.16.4 VectorBuilder GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 VectorBuilder Recent Developments/Updates
9.16.6 VectorBuilder Competitive Strengths & Weaknesses
9.17 GenScript ProBio
9.17.1 GenScript ProBio Details
9.17.2 GenScript ProBio Major Business
9.17.3 GenScript ProBio GMP-grade AAV Vector Manufacturing Service Product and Services
9.17.4 GenScript ProBio GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 GenScript ProBio Recent Developments/Updates
9.17.6 GenScript ProBio Competitive Strengths & Weaknesses
9.18 PackGene Biotech
9.18.1 PackGene Biotech Details
9.18.2 PackGene Biotech Major Business
9.18.3 PackGene Biotech GMP-grade AAV Vector Manufacturing Service Product and Services
9.18.4 PackGene Biotech GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 PackGene Biotech Recent Developments/Updates
9.18.6 PackGene Biotech Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 GMP-grade AAV Vector Manufacturing Service Industry Chain
10.2 GMP-grade AAV Vector Manufacturing Service Upstream Analysis
10.3 GMP-grade AAV Vector Manufacturing Service Midstream Analysis
10.4 GMP-grade AAV Vector Manufacturing Service Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World GMP-grade AAV Vector Manufacturing Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World GMP-grade AAV Vector Manufacturing Service Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World GMP-grade AAV Vector Manufacturing Service Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World GMP-grade AAV Vector Manufacturing Service Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World GMP-grade AAV Vector Manufacturing Service Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World GMP-grade AAV Vector Manufacturing Service Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World GMP-grade AAV Vector Manufacturing Service Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World GMP-grade AAV Vector Manufacturing Service Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World GMP-grade AAV Vector Manufacturing Service Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key GMP-grade AAV Vector Manufacturing Service Players in 2025
Table 12. World GMP-grade AAV Vector Manufacturing Service Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global GMP-grade AAV Vector Manufacturing Service Company Evaluation Quadrant
Table 14. Head Office of Key GMP-grade AAV Vector Manufacturing Service Players
Table 15. GMP-grade AAV Vector Manufacturing Service Market: Company Product Type Footprint
Table 16. GMP-grade AAV Vector Manufacturing Service Market: Company Product Application Footprint
Table 17. GMP-grade AAV Vector Manufacturing Service Mergers & Acquisitions Activity
Table 18. United States VS China GMP-grade AAV Vector Manufacturing Service Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China GMP-grade AAV Vector Manufacturing Service Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based GMP-grade AAV Vector Manufacturing Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies GMP-grade AAV Vector Manufacturing Service Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies GMP-grade AAV Vector Manufacturing Service Revenue Market Share (2021-2026)
Table 23. China Based GMP-grade AAV Vector Manufacturing Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies GMP-grade AAV Vector Manufacturing Service Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies GMP-grade AAV Vector Manufacturing Service Revenue Market Share (2021-2026)
Table 26. Rest of World Based GMP-grade AAV Vector Manufacturing Service Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies GMP-grade AAV Vector Manufacturing Service Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies GMP-grade AAV Vector Manufacturing Service Revenue Market Share (2021-2026)
Table 29. World GMP-grade AAV Vector Manufacturing Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World GMP-grade AAV Vector Manufacturing Service Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World GMP-grade AAV Vector Manufacturing Service Market Size by Type (2027-2032) & (USD Million)
Table 32. World GMP-grade AAV Vector Manufacturing Service Market Size by Development Stage, (USD Million), 2021 & 2025 & 2032
Table 33. World GMP-grade AAV Vector Manufacturing Service Market Size Value by Development Stage (2021-2026) & (USD Million)
Table 34. World GMP-grade AAV Vector Manufacturing Service Market Size by Development Stage (2027-2032) & (USD Million)
Table 35. World GMP-grade AAV Vector Manufacturing Service Market Size by Production Platform, (USD Million), 2021 & 2025 & 2032
Table 36. World GMP-grade AAV Vector Manufacturing Service Market Size Value by Production Platform (2021-2026) & (USD Million)
Table 37. World GMP-grade AAV Vector Manufacturing Service Market Size by Production Platform (2027-2032) & (USD Million)
Table 38. World GMP-grade AAV Vector Manufacturing Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World GMP-grade AAV Vector Manufacturing Service Market Size by Application (2021-2026) & (USD Million)
Table 40. World GMP-grade AAV Vector Manufacturing Service Market Size by Application (2027-2032) & (USD Million)
Table 41. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 42. Thermo Fisher Scientific Major Business
Table 43. Thermo Fisher Scientific GMP-grade AAV Vector Manufacturing Service Product and Services
Table 44. Thermo Fisher Scientific GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Thermo Fisher Scientific Recent Developments/Updates
Table 46. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 47. Lonza Basic Information, Manufacturing Base and Competitors
Table 48. Lonza Major Business
Table 49. Lonza GMP-grade AAV Vector Manufacturing Service Product and Services
Table 50. Lonza GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Lonza Recent Developments/Updates
Table 52. Lonza Competitive Strengths & Weaknesses
Table 53. Charles River Laboratories Basic Information, Manufacturing Base and Competitors
Table 54. Charles River Laboratories Major Business
Table 55. Charles River Laboratories GMP-grade AAV Vector Manufacturing Service Product and Services
Table 56. Charles River Laboratories GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Charles River Laboratories Recent Developments/Updates
Table 58. Charles River Laboratories Competitive Strengths & Weaknesses
Table 59. Catalent Basic Information, Manufacturing Base and Competitors
Table 60. Catalent Major Business
Table 61. Catalent GMP-grade AAV Vector Manufacturing Service Product and Services
Table 62. Catalent GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Catalent Recent Developments/Updates
Table 64. Catalent Competitive Strengths & Weaknesses
Table 65. AGC Biologics Basic Information, Manufacturing Base and Competitors
Table 66. AGC Biologics Major Business
Table 67. AGC Biologics GMP-grade AAV Vector Manufacturing Service Product and Services
Table 68. AGC Biologics GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. AGC Biologics Recent Developments/Updates
Table 70. AGC Biologics Competitive Strengths & Weaknesses
Table 71. SK pharmteco Basic Information, Manufacturing Base and Competitors
Table 72. SK pharmteco Major Business
Table 73. SK pharmteco GMP-grade AAV Vector Manufacturing Service Product and Services
Table 74. SK pharmteco GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. SK pharmteco Recent Developments/Updates
Table 76. SK pharmteco Competitive Strengths & Weaknesses
Table 77. OXB Basic Information, Manufacturing Base and Competitors
Table 78. OXB Major Business
Table 79. OXB GMP-grade AAV Vector Manufacturing Service Product and Services
Table 80. OXB GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. OXB Recent Developments/Updates
Table 82. OXB Competitive Strengths & Weaknesses
Table 83. Forge Biologics Basic Information, Manufacturing Base and Competitors
Table 84. Forge Biologics Major Business
Table 85. Forge Biologics GMP-grade AAV Vector Manufacturing Service Product and Services
Table 86. Forge Biologics GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Forge Biologics Recent Developments/Updates
Table 88. Forge Biologics Competitive Strengths & Weaknesses
Table 89. Viralgen Basic Information, Manufacturing Base and Competitors
Table 90. Viralgen Major Business
Table 91. Viralgen GMP-grade AAV Vector Manufacturing Service Product and Services
Table 92. Viralgen GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Viralgen Recent Developments/Updates
Table 94. Viralgen Competitive Strengths & Weaknesses
Table 95. Andelyn Biosciences Basic Information, Manufacturing Base and Competitors
Table 96. Andelyn Biosciences Major Business
Table 97. Andelyn Biosciences GMP-grade AAV Vector Manufacturing Service Product and Services
Table 98. Andelyn Biosciences GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Andelyn Biosciences Recent Developments/Updates
Table 100. Andelyn Biosciences Competitive Strengths & Weaknesses
Table 101. Resilience Basic Information, Manufacturing Base and Competitors
Table 102. Resilience Major Business
Table 103. Resilience GMP-grade AAV Vector Manufacturing Service Product and Services
Table 104. Resilience GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Resilience Recent Developments/Updates
Table 106. Resilience Competitive Strengths & Weaknesses
Table 107. Advanced Therapies Basic Information, Manufacturing Base and Competitors
Table 108. Advanced Therapies Major Business
Table 109. Advanced Therapies GMP-grade AAV Vector Manufacturing Service Product and Services
Table 110. Advanced Therapies GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Advanced Therapies Recent Developments/Updates
Table 112. Advanced Therapies Competitive Strengths & Weaknesses
Table 113. IDT Biologika Basic Information, Manufacturing Base and Competitors
Table 114. IDT Biologika Major Business
Table 115. IDT Biologika GMP-grade AAV Vector Manufacturing Service Product and Services
Table 116. IDT Biologika GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. IDT Biologika Recent Developments/Updates
Table 118. IDT Biologika Competitive Strengths & Weaknesses
Table 119. Matica Bio Basic Information, Manufacturing Base and Competitors
Table 120. Matica Bio Major Business
Table 121. Matica Bio GMP-grade AAV Vector Manufacturing Service Product and Services
Table 122. Matica Bio GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Matica Bio Recent Developments/Updates
Table 124. Matica Bio Competitive Strengths & Weaknesses
Table 125. Takara Bio Basic Information, Manufacturing Base and Competitors
Table 126. Takara Bio Major Business
Table 127. Takara Bio GMP-grade AAV Vector Manufacturing Service Product and Services
Table 128. Takara Bio GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Takara Bio Recent Developments/Updates
Table 130. Takara Bio Competitive Strengths & Weaknesses
Table 131. VectorBuilder Basic Information, Manufacturing Base and Competitors
Table 132. VectorBuilder Major Business
Table 133. VectorBuilder GMP-grade AAV Vector Manufacturing Service Product and Services
Table 134. VectorBuilder GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. VectorBuilder Recent Developments/Updates
Table 136. VectorBuilder Competitive Strengths & Weaknesses
Table 137. GenScript ProBio Basic Information, Manufacturing Base and Competitors
Table 138. GenScript ProBio Major Business
Table 139. GenScript ProBio GMP-grade AAV Vector Manufacturing Service Product and Services
Table 140. GenScript ProBio GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. GenScript ProBio Recent Developments/Updates
Table 142. GenScript ProBio Competitive Strengths & Weaknesses
Table 143. PackGene Biotech Basic Information, Manufacturing Base and Competitors
Table 144. PackGene Biotech Major Business
Table 145. PackGene Biotech GMP-grade AAV Vector Manufacturing Service Product and Services
Table 146. PackGene Biotech GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. PackGene Biotech Recent Developments/Updates
Table 148. PackGene Biotech Competitive Strengths & Weaknesses
Table 149. Global Key Players of GMP-grade AAV Vector Manufacturing Service Upstream (Raw Materials)
Table 150. Global GMP-grade AAV Vector Manufacturing Service Typical Customers
Table 1. World GMP-grade AAV Vector Manufacturing Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World GMP-grade AAV Vector Manufacturing Service Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World GMP-grade AAV Vector Manufacturing Service Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World GMP-grade AAV Vector Manufacturing Service Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World GMP-grade AAV Vector Manufacturing Service Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World GMP-grade AAV Vector Manufacturing Service Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World GMP-grade AAV Vector Manufacturing Service Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World GMP-grade AAV Vector Manufacturing Service Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World GMP-grade AAV Vector Manufacturing Service Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key GMP-grade AAV Vector Manufacturing Service Players in 2025
Table 12. World GMP-grade AAV Vector Manufacturing Service Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global GMP-grade AAV Vector Manufacturing Service Company Evaluation Quadrant
Table 14. Head Office of Key GMP-grade AAV Vector Manufacturing Service Players
Table 15. GMP-grade AAV Vector Manufacturing Service Market: Company Product Type Footprint
Table 16. GMP-grade AAV Vector Manufacturing Service Market: Company Product Application Footprint
Table 17. GMP-grade AAV Vector Manufacturing Service Mergers & Acquisitions Activity
Table 18. United States VS China GMP-grade AAV Vector Manufacturing Service Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China GMP-grade AAV Vector Manufacturing Service Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based GMP-grade AAV Vector Manufacturing Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies GMP-grade AAV Vector Manufacturing Service Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies GMP-grade AAV Vector Manufacturing Service Revenue Market Share (2021-2026)
Table 23. China Based GMP-grade AAV Vector Manufacturing Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies GMP-grade AAV Vector Manufacturing Service Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies GMP-grade AAV Vector Manufacturing Service Revenue Market Share (2021-2026)
Table 26. Rest of World Based GMP-grade AAV Vector Manufacturing Service Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies GMP-grade AAV Vector Manufacturing Service Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies GMP-grade AAV Vector Manufacturing Service Revenue Market Share (2021-2026)
Table 29. World GMP-grade AAV Vector Manufacturing Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World GMP-grade AAV Vector Manufacturing Service Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World GMP-grade AAV Vector Manufacturing Service Market Size by Type (2027-2032) & (USD Million)
Table 32. World GMP-grade AAV Vector Manufacturing Service Market Size by Development Stage, (USD Million), 2021 & 2025 & 2032
Table 33. World GMP-grade AAV Vector Manufacturing Service Market Size Value by Development Stage (2021-2026) & (USD Million)
Table 34. World GMP-grade AAV Vector Manufacturing Service Market Size by Development Stage (2027-2032) & (USD Million)
Table 35. World GMP-grade AAV Vector Manufacturing Service Market Size by Production Platform, (USD Million), 2021 & 2025 & 2032
Table 36. World GMP-grade AAV Vector Manufacturing Service Market Size Value by Production Platform (2021-2026) & (USD Million)
Table 37. World GMP-grade AAV Vector Manufacturing Service Market Size by Production Platform (2027-2032) & (USD Million)
Table 38. World GMP-grade AAV Vector Manufacturing Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World GMP-grade AAV Vector Manufacturing Service Market Size by Application (2021-2026) & (USD Million)
Table 40. World GMP-grade AAV Vector Manufacturing Service Market Size by Application (2027-2032) & (USD Million)
Table 41. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 42. Thermo Fisher Scientific Major Business
Table 43. Thermo Fisher Scientific GMP-grade AAV Vector Manufacturing Service Product and Services
Table 44. Thermo Fisher Scientific GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Thermo Fisher Scientific Recent Developments/Updates
Table 46. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 47. Lonza Basic Information, Manufacturing Base and Competitors
Table 48. Lonza Major Business
Table 49. Lonza GMP-grade AAV Vector Manufacturing Service Product and Services
Table 50. Lonza GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Lonza Recent Developments/Updates
Table 52. Lonza Competitive Strengths & Weaknesses
Table 53. Charles River Laboratories Basic Information, Manufacturing Base and Competitors
Table 54. Charles River Laboratories Major Business
Table 55. Charles River Laboratories GMP-grade AAV Vector Manufacturing Service Product and Services
Table 56. Charles River Laboratories GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Charles River Laboratories Recent Developments/Updates
Table 58. Charles River Laboratories Competitive Strengths & Weaknesses
Table 59. Catalent Basic Information, Manufacturing Base and Competitors
Table 60. Catalent Major Business
Table 61. Catalent GMP-grade AAV Vector Manufacturing Service Product and Services
Table 62. Catalent GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Catalent Recent Developments/Updates
Table 64. Catalent Competitive Strengths & Weaknesses
Table 65. AGC Biologics Basic Information, Manufacturing Base and Competitors
Table 66. AGC Biologics Major Business
Table 67. AGC Biologics GMP-grade AAV Vector Manufacturing Service Product and Services
Table 68. AGC Biologics GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. AGC Biologics Recent Developments/Updates
Table 70. AGC Biologics Competitive Strengths & Weaknesses
Table 71. SK pharmteco Basic Information, Manufacturing Base and Competitors
Table 72. SK pharmteco Major Business
Table 73. SK pharmteco GMP-grade AAV Vector Manufacturing Service Product and Services
Table 74. SK pharmteco GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. SK pharmteco Recent Developments/Updates
Table 76. SK pharmteco Competitive Strengths & Weaknesses
Table 77. OXB Basic Information, Manufacturing Base and Competitors
Table 78. OXB Major Business
Table 79. OXB GMP-grade AAV Vector Manufacturing Service Product and Services
Table 80. OXB GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. OXB Recent Developments/Updates
Table 82. OXB Competitive Strengths & Weaknesses
Table 83. Forge Biologics Basic Information, Manufacturing Base and Competitors
Table 84. Forge Biologics Major Business
Table 85. Forge Biologics GMP-grade AAV Vector Manufacturing Service Product and Services
Table 86. Forge Biologics GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Forge Biologics Recent Developments/Updates
Table 88. Forge Biologics Competitive Strengths & Weaknesses
Table 89. Viralgen Basic Information, Manufacturing Base and Competitors
Table 90. Viralgen Major Business
Table 91. Viralgen GMP-grade AAV Vector Manufacturing Service Product and Services
Table 92. Viralgen GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Viralgen Recent Developments/Updates
Table 94. Viralgen Competitive Strengths & Weaknesses
Table 95. Andelyn Biosciences Basic Information, Manufacturing Base and Competitors
Table 96. Andelyn Biosciences Major Business
Table 97. Andelyn Biosciences GMP-grade AAV Vector Manufacturing Service Product and Services
Table 98. Andelyn Biosciences GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Andelyn Biosciences Recent Developments/Updates
Table 100. Andelyn Biosciences Competitive Strengths & Weaknesses
Table 101. Resilience Basic Information, Manufacturing Base and Competitors
Table 102. Resilience Major Business
Table 103. Resilience GMP-grade AAV Vector Manufacturing Service Product and Services
Table 104. Resilience GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Resilience Recent Developments/Updates
Table 106. Resilience Competitive Strengths & Weaknesses
Table 107. Advanced Therapies Basic Information, Manufacturing Base and Competitors
Table 108. Advanced Therapies Major Business
Table 109. Advanced Therapies GMP-grade AAV Vector Manufacturing Service Product and Services
Table 110. Advanced Therapies GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Advanced Therapies Recent Developments/Updates
Table 112. Advanced Therapies Competitive Strengths & Weaknesses
Table 113. IDT Biologika Basic Information, Manufacturing Base and Competitors
Table 114. IDT Biologika Major Business
Table 115. IDT Biologika GMP-grade AAV Vector Manufacturing Service Product and Services
Table 116. IDT Biologika GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. IDT Biologika Recent Developments/Updates
Table 118. IDT Biologika Competitive Strengths & Weaknesses
Table 119. Matica Bio Basic Information, Manufacturing Base and Competitors
Table 120. Matica Bio Major Business
Table 121. Matica Bio GMP-grade AAV Vector Manufacturing Service Product and Services
Table 122. Matica Bio GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Matica Bio Recent Developments/Updates
Table 124. Matica Bio Competitive Strengths & Weaknesses
Table 125. Takara Bio Basic Information, Manufacturing Base and Competitors
Table 126. Takara Bio Major Business
Table 127. Takara Bio GMP-grade AAV Vector Manufacturing Service Product and Services
Table 128. Takara Bio GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Takara Bio Recent Developments/Updates
Table 130. Takara Bio Competitive Strengths & Weaknesses
Table 131. VectorBuilder Basic Information, Manufacturing Base and Competitors
Table 132. VectorBuilder Major Business
Table 133. VectorBuilder GMP-grade AAV Vector Manufacturing Service Product and Services
Table 134. VectorBuilder GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. VectorBuilder Recent Developments/Updates
Table 136. VectorBuilder Competitive Strengths & Weaknesses
Table 137. GenScript ProBio Basic Information, Manufacturing Base and Competitors
Table 138. GenScript ProBio Major Business
Table 139. GenScript ProBio GMP-grade AAV Vector Manufacturing Service Product and Services
Table 140. GenScript ProBio GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. GenScript ProBio Recent Developments/Updates
Table 142. GenScript ProBio Competitive Strengths & Weaknesses
Table 143. PackGene Biotech Basic Information, Manufacturing Base and Competitors
Table 144. PackGene Biotech Major Business
Table 145. PackGene Biotech GMP-grade AAV Vector Manufacturing Service Product and Services
Table 146. PackGene Biotech GMP-grade AAV Vector Manufacturing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. PackGene Biotech Recent Developments/Updates
Table 148. PackGene Biotech Competitive Strengths & Weaknesses
Table 149. Global Key Players of GMP-grade AAV Vector Manufacturing Service Upstream (Raw Materials)
Table 150. Global GMP-grade AAV Vector Manufacturing Service Typical Customers
LIST OF FIGURES
Figure 1. GMP-grade AAV Vector Manufacturing Service Picture
Figure 2. World GMP-grade AAV Vector Manufacturing Service Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World GMP-grade AAV Vector Manufacturing Service Total Revenue (2021-2032) & (USD Million)
Figure 4. World GMP-grade AAV Vector Manufacturing Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World GMP-grade AAV Vector Manufacturing Service Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032) & (USD Million)
Figure 13. GMP-grade AAV Vector Manufacturing Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032) & (USD Million)
Figure 16. World GMP-grade AAV Vector Manufacturing Service Consumption Value Market Share by Region (2021-2032)
Figure 17. United States GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032) & (USD Million)
Figure 18. China GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032) & (USD Million)
Figure 23. India GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of GMP-grade AAV Vector Manufacturing Service by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for GMP-grade AAV Vector Manufacturing Service Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for GMP-grade AAV Vector Manufacturing Service Markets in 2025
Figure 27. United States VS China: GMP-grade AAV Vector Manufacturing Service Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: GMP-grade AAV Vector Manufacturing Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World GMP-grade AAV Vector Manufacturing Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World GMP-grade AAV Vector Manufacturing Service Market Size Market Share by Type in 2025
Figure 31. GMP Drug Substance Manufacturing
Figure 32. GMP Drug Substance and Fill-Finish
Figure 33. End-to-End CMC and Manufacturing
Figure 34. World GMP-grade AAV Vector Manufacturing Service Market Size Market Share by Type (2021-2032)
Figure 35. World GMP-grade AAV Vector Manufacturing Service Market Size by Development Stage, (USD Million), 2021 & 2025 & 2032
Figure 36. World GMP-grade AAV Vector Manufacturing Service Market Size Market Share by Development Stage in 2025
Figure 37. Early Clinical Manufacturing
Figure 38. Late-stage Clinical Manufacturing
Figure 39. PPQ and Commercial Manufacturing
Figure 40. World GMP-grade AAV Vector Manufacturing Service Market Size Market Share by Development Stage (2021-2032)
Figure 41. World GMP-grade AAV Vector Manufacturing Service Market Size by Production Platform, (USD Million), 2021 & 2025 & 2032
Figure 42. World GMP-grade AAV Vector Manufacturing Service Market Size Market Share by Production Platform in 2025
Figure 43. Adherent HEK293
Figure 44. Suspension HEK293
Figure 45. Baculovirus-Sf9
Figure 46. Other
Figure 47. World GMP-grade AAV Vector Manufacturing Service Market Size Market Share by Production Platform (2021-2032)
Figure 48. World GMP-grade AAV Vector Manufacturing Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World GMP-grade AAV Vector Manufacturing Service Market Size Market Share by Application in 2025
Figure 50. Biotechnology Companies
Figure 51. Pharmaceutical Companies
Figure 52. Other
Figure 53. World GMP-grade AAV Vector Manufacturing Service Market Size Market Share by Application (2021-2032)
Figure 54. GMP-grade AAV Vector Manufacturing Service Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source
Figure 1. GMP-grade AAV Vector Manufacturing Service Picture
Figure 2. World GMP-grade AAV Vector Manufacturing Service Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World GMP-grade AAV Vector Manufacturing Service Total Revenue (2021-2032) & (USD Million)
Figure 4. World GMP-grade AAV Vector Manufacturing Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World GMP-grade AAV Vector Manufacturing Service Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032) & (USD Million)
Figure 13. GMP-grade AAV Vector Manufacturing Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032) & (USD Million)
Figure 16. World GMP-grade AAV Vector Manufacturing Service Consumption Value Market Share by Region (2021-2032)
Figure 17. United States GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032) & (USD Million)
Figure 18. China GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032) & (USD Million)
Figure 23. India GMP-grade AAV Vector Manufacturing Service Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of GMP-grade AAV Vector Manufacturing Service by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for GMP-grade AAV Vector Manufacturing Service Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for GMP-grade AAV Vector Manufacturing Service Markets in 2025
Figure 27. United States VS China: GMP-grade AAV Vector Manufacturing Service Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: GMP-grade AAV Vector Manufacturing Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World GMP-grade AAV Vector Manufacturing Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World GMP-grade AAV Vector Manufacturing Service Market Size Market Share by Type in 2025
Figure 31. GMP Drug Substance Manufacturing
Figure 32. GMP Drug Substance and Fill-Finish
Figure 33. End-to-End CMC and Manufacturing
Figure 34. World GMP-grade AAV Vector Manufacturing Service Market Size Market Share by Type (2021-2032)
Figure 35. World GMP-grade AAV Vector Manufacturing Service Market Size by Development Stage, (USD Million), 2021 & 2025 & 2032
Figure 36. World GMP-grade AAV Vector Manufacturing Service Market Size Market Share by Development Stage in 2025
Figure 37. Early Clinical Manufacturing
Figure 38. Late-stage Clinical Manufacturing
Figure 39. PPQ and Commercial Manufacturing
Figure 40. World GMP-grade AAV Vector Manufacturing Service Market Size Market Share by Development Stage (2021-2032)
Figure 41. World GMP-grade AAV Vector Manufacturing Service Market Size by Production Platform, (USD Million), 2021 & 2025 & 2032
Figure 42. World GMP-grade AAV Vector Manufacturing Service Market Size Market Share by Production Platform in 2025
Figure 43. Adherent HEK293
Figure 44. Suspension HEK293
Figure 45. Baculovirus-Sf9
Figure 46. Other
Figure 47. World GMP-grade AAV Vector Manufacturing Service Market Size Market Share by Production Platform (2021-2032)
Figure 48. World GMP-grade AAV Vector Manufacturing Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World GMP-grade AAV Vector Manufacturing Service Market Size Market Share by Application in 2025
Figure 50. Biotechnology Companies
Figure 51. Pharmaceutical Companies
Figure 52. Other
Figure 53. World GMP-grade AAV Vector Manufacturing Service Market Size Market Share by Application (2021-2032)
Figure 54. GMP-grade AAV Vector Manufacturing Service Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source
